Univest Corp of Pennsylvania Acquires 337 Shares of CVS Health Corporation (CVS)
Univest Corp of Pennsylvania increased its position in shares of CVS Health Corporation (NYSE:CVS) by 0.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 39,503 shares of the pharmacy operator’s stock after buying an additional 337 shares during the period. CVS Health Corporation makes up approximately 1.6% of Univest Corp of Pennsylvania’s portfolio, making the stock its 23rd largest position. Univest Corp of Pennsylvania’s holdings in CVS Health Corporation were worth $3,515,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Bridge Creek Capital Management LLC raised its position in shares of CVS Health Corporation by 0.5% in the second quarter. Bridge Creek Capital Management LLC now owns 39,538 shares of the pharmacy operator’s stock worth $3,785,000 after buying an additional 179 shares in the last quarter. Ngam Advisors L.P. raised its stake in CVS Health Corporation by 1.9% in the second quarter. Ngam Advisors L.P. now owns 233,294 shares of the pharmacy operator’s stock worth $22,336,000 after buying an additional 4,315 shares during the period. BP PLC raised its stake in CVS Health Corporation by 17.9% in the second quarter. BP PLC now owns 138,000 shares of the pharmacy operator’s stock worth $13,211,000 after buying an additional 21,000 shares during the period. Retirement Systems of Alabama raised its stake in CVS Health Corporation by 8.7% in the second quarter. Retirement Systems of Alabama now owns 1,043,349 shares of the pharmacy operator’s stock worth $99,890,000 after buying an additional 83,608 shares during the period. Finally, Veritas Asset Management LLP raised its stake in CVS Health Corporation by 10.1% in the second quarter. Veritas Asset Management LLP now owns 4,808,477 shares of the pharmacy operator’s stock worth $460,364,000 after buying an additional 439,848 shares during the period. 80.44% of the stock is currently owned by institutional investors and hedge funds.
Shares of CVS Health Corporation (NYSE:CVS) traded up 1.33% during midday trading on Wednesday, hitting $76.89. The company had a trading volume of 12,781,302 shares. The stock’s 50-day moving average price is $81.16 and its 200-day moving average price is $91.23. CVS Health Corporation has a one year low of $69.30 and a one year high of $106.67. The stock has a market capitalization of $82.00 billion, a price-to-earnings ratio of 16.48 and a beta of 0.88.
CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.57 by $0.07. The business had revenue of $44.60 billion for the quarter, compared to the consensus estimate of $45.29 billion. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. The firm’s quarterly revenue was up 15.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.28 earnings per share. Analysts predict that CVS Health Corporation will post $5.81 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, November 3rd. Shareholders of record on Monday, October 24th were issued a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date of this dividend was Thursday, October 20th. CVS Health Corporation’s dividend payout ratio is presently 36.40%.
WARNING: “Univest Corp of Pennsylvania Acquires 337 Shares of CVS Health Corporation (CVS)” was reported by Financial Market News and is owned by of Financial Market News. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this story can be accessed at http://www.financial-market-news.com/univest-corp-of-pennsylvania-acquires-337-shares-of-cvs-health-corporation-cvs/1211148/.
CVS has been the topic of a number of research analyst reports. Credit Suisse Group AG reaffirmed an “outperform” rating and issued a $110.00 target price (down previously from $115.00) on shares of CVS Health Corporation in a report on Tuesday, October 4th. Robert W. Baird lowered their target price on CVS Health Corporation from $114.00 to $104.00 and set an “outperform” rating on the stock in a report on Monday, October 3rd. Leerink Swann reissued an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of CVS Health Corporation in a report on Sunday, October 2nd. Vetr raised CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $98.36 price objective on the stock in a report on Monday, October 24th. Finally, Mizuho reissued a “buy” rating and set a $111.00 price objective on shares of CVS Health Corporation in a report on Friday, September 30th. Five analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $106.24.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.